iNtRON Biotechnology Inc (048530) — Capital Reinvestment Ratio
iNtRON Biotechnology Inc (048530) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.94 Billion) in capital expenditures (₩321.62 Million). Check iNtRON Biotechnology Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
iNtRON Biotechnology Inc Capital Reinvestment Ratio (2015–2023)
This chart tracks iNtRON Biotechnology Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see iNtRON Biotechnology Inc (048530) cash conversion ratio.
Annual Capital Reinvestment Ratio for iNtRON Biotechnology Inc (2015–2023)
Year-by-year Capital Reinvestment Ratio for iNtRON Biotechnology Inc from 2015 to 2023. See iNtRON Biotechnology Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 3.06x | ₩3.12 Billion | ₩9.55 Billion | ▲ +721.6% |
| 2022 | 0.37x | ₩5.98 Billion | ₩2.23 Billion | ▲ +101.6% |
| 2021 | 0.18x | ₩16.47 Billion | ₩3.05 Billion | ▼ -72.8% |
| 2020 | 0.68x | ₩7.13 Billion | ₩4.85 Billion | ▲ +419.1% |
| 2018 | 0.13x | ₩4.20 Billion | ₩550.58 Million | ▼ -96.5% |
| 2015 | 3.71x | ₩1.70 Billion | ₩6.30 Billion | — |